Showing results (541-550 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|December 19, 2012
APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessationR L Ashare, J H Karlawish, E P Wileyto, et al.
The Pharmacogenomics Journal|September 24, 2014
Impact of NEGR1 genetic variability on psychological traits of patients with eating disordersC Gamero-Villarroel, L María González, I Gordillo, et al.
The Pharmacogenomics Journal|October 8, 2014
An evaluation of regulatory and commercial barriers to stratified medicine development and adoptionN A Meadows, A Morrison, D A Brindley, et al.
The Pharmacogenomics Journal|October 15, 2014
Opioid-induced respiratory depression: ABCB1 transporter pharmacogeneticsS Sadhasivam, V Chidambaran, X Zhang, et al.
The Pharmacogenomics Journal|May 1, 2013
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependentV Michaud, Y Kreutz, T Skaar, et al.
The Pharmacogenomics Journal|June 12, 2013
Functional characterization of 32 CYP2C9 allelic variantsY Niinuma, T Saito, M Takahashi, et al.
The Pharmacogenomics Journal|June 12, 2013
Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapyL Benhaim, A Gerger, P Bohanes, et al.
The Pharmacogenomics Journal|August 21, 2013
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecanA Sebio, D Páez, J Salazar, et al.
The Pharmacogenomics Journal|July 17, 2013
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersJ T McCracken, K K Badashova, D J Posey, et al.
The Pharmacogenomics Journal|January 7, 2015
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effectsS Sadhasivam, X Zhang, V Chidambaran, et al.
Pageof 135